CN Stock MarketDetailed Quotes
600812 North China Pharmaceutical
- 5.66
- -0.17-2.92%
Market Closed Dec 13 15:00 CST
9.71BMarket Cap123.04P/E (TTM)
5.82High5.66Low144.90KlotVolume5.79Open5.83Pre Close82.78MTurnover0.85%Turnover Ratio1886.67P/E (Static)1.72BShares6.2252wk High1.81P/B9.71BFloat Cap3.8252wk Low6.41Limit Up1.72BShs Float20.14Historical High5.25Limit Down2.74%Amplitude0.62Historical Low0.01Dividend TTM5.71Avg Price94.88KlotAsk0.18%Div YieldTTM100Lot Size45.29KlotBid
North China Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -12.98%5.59B | -8.82%3.7B | -8.66%1.81B | -15.27%8.46B | -9.93%6.43B | -3.77%4.06B | -1.96%1.98B | 11.99%9.98B | 9.28%7.14B | -0.11%4.22B |
| Refunds of taxes and levies | 45.88%92.58M | 32.58%54.33M | 16.77%23.91M | -33.57%101.53M | -51.29%63.47M | -59.61%40.98M | -26.99%20.48M | 9.86%152.84M | 10.93%130.3M | 36.02%101.47M |
| Cash received relating to other operating activities | 233.59%504.2M | 401.88%535.59M | 673.27%443.3M | -15.15%198.11M | -51.82%151.14M | -44.37%106.72M | -38.84%57.33M | -30.43%233.48M | 6.77%313.7M | 8.70%191.83M |
| Cash inflows from operating activities | -6.80%6.19B | 1.99%4.29B | 10.62%2.27B | -15.54%8.76B | -12.37%6.64B | -6.75%4.21B | -3.90%2.06B | 10.44%10.37B | 9.20%7.58B | 0.84%4.51B |
| Goods services cash paid | -14.08%2.6B | -6.99%1.74B | 4.19%860.48M | -26.25%3.98B | -25.29%3.03B | -18.46%1.87B | -21.12%825.9M | 25.46%5.4B | 24.15%4.06B | 12.41%2.3B |
| Staff behalf paid | 0.85%977.26M | 1.46%644.25M | 7.02%334.89M | -9.26%1.36B | -4.28%969.04M | -7.66%634.97M | -16.33%312.91M | 23.30%1.49B | 9.32%1.01B | 9.98%687.64M |
| All taxes paid | -32.72%333.32M | -34.43%224.03M | -40.24%111.3M | 6.86%608.46M | 13.11%495.41M | 23.57%341.65M | 7.76%186.23M | -6.58%569.41M | -2.37%438M | -9.60%276.48M |
| Cash paid relating to other operating activities | -21.64%1.22B | -26.97%798.29M | -26.31%399.51M | -5.99%1.78B | 0.90%1.55B | 7.14%1.09B | 6.84%542.17M | -14.14%1.9B | -7.06%1.54B | -18.83%1.02B |
| Cash outflows from operating activities | -15.15%5.13B | -13.55%3.41B | -8.62%1.71B | -17.42%7.73B | -14.17%6.05B | -7.91%3.94B | -11.14%1.87B | 12.31%9.36B | 11.87%7.05B | 1.18%4.28B |
| Net cash flows from operating activities | 78.26%1.06B | 233.30%883.18M | 201.87%567.08M | 1.98%1.02B | 11.39%593.73M | 14.75%264.99M | 404.11%187.86M | -4.37%1B | -17.04%533.02M | -5.08%230.93M |
| Investing cash flow | ||||||||||
| Cash received from returns on investments | ---- | ---- | ---- | -31.51%589.47K | --589.47K | ---- | ---- | -49.03%860.71K | --0 | ---- |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 81.85%1.26M | 236.50%1.26M | ---- | -96.90%690.95K | -96.87%690.95K | -98.30%373.4K | -53.01%230K | 240.18%22.26M | 2,194.38%22.05M | 2,189.19%21.98M |
| Cash inflows from investing activities | -1.87%1.26M | 236.50%1.26M | ---- | -94.46%1.28M | -94.19%1.28M | -98.30%373.4K | -53.01%230K | 180.85%23.12M | 1,124.40%22.05M | 1,121.03%21.98M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | 26.77%481.88M | 27.66%328.68M | 64.17%192.68M | 13.36%623.04M | -3.76%380.13M | 25.17%257.48M | 10.54%117.37M | 0.38%549.58M | -3.40%394.99M | -30.74%205.7M |
| Cash paid to acquire investments | ---- | ---- | ---- | 12,900.00%260M | --50M | ---- | ---- | -99.17%2M | ---- | ---- |
| Cash outflows from investing activities | 12.03%481.88M | 27.66%328.68M | 64.17%192.68M | 60.09%883.04M | 8.90%430.13M | 25.17%257.48M | 10.54%117.37M | -29.96%551.58M | -39.13%394.99M | -61.69%205.7M |
| Net cash flows from investing activities | -12.07%-480.62M | -27.35%-327.43M | -64.49%-192.68M | -66.85%-881.75M | -14.99%-428.85M | -39.94%-257.1M | -10.83%-117.14M | 32.18%-528.46M | 42.37%-372.94M | 65.67%-183.72M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | --903M | --900M | ---- | 68.29%10M | ---- | ---- | ---- | --5.94M | ---- | ---- |
| Cash from borrowing | 4.58%7.64B | 4.10%4.85B | -34.91%1.85B | -4.30%9.83B | -1.04%7.3B | -22.85%4.66B | -19.24%2.84B | 0.19%10.27B | -2.12%7.38B | 25.35%6.04B |
| Cash received relating to other financing activities | -22.67%707.36M | -16.07%707.36M | -41.51%176.51M | -25.03%945.44M | -29.98%914.77M | -32.92%842.77M | -57.29%301.8M | 5.80%1.26B | 32.71%1.31B | 114.98%1.26B |
| Cash inflows from financing activities | 12.53%9.25B | 17.36%6.46B | -35.55%2.02B | -6.53%10.78B | -5.39%8.22B | -24.58%5.5B | -25.61%3.14B | 0.82%11.54B | 1.90%8.68B | 35.05%7.3B |
| Borrowing repayment | 1.44%6.97B | -1.12%4.26B | -19.27%1.92B | -27.57%9.58B | -28.81%6.87B | -32.24%4.31B | -37.36%2.38B | 38.56%13.23B | 60.10%9.65B | 79.98%6.36B |
| Dividend interest payment | 6.59%391.69M | -6.25%261.78M | -9.82%118.5M | -30.39%516.22M | -39.96%367.47M | -20.89%279.23M | -21.79%131.41M | -0.69%741.6M | 9.85%612M | 3.02%352.96M |
| -Including:Cash payments for dividends or profit to minority shareholders | 25.28%22.1M | 25.28%22.1M | ---- | ---- | --17.64M | --17.64M | ---- | ---- | ---- | ---- |
| Cash payments relating to other financing activities | 25.11%1.6B | 61.11%1.58B | 47.48%475.79M | -32.03%1.39B | -25.96%1.28B | -38.34%978.7M | -65.16%322.61M | 145.07%2.05B | 97.58%1.73B | 193.52%1.59B |
| Cash outflows from financing activities | 5.22%8.97B | 9.56%6.1B | -11.22%2.51B | -28.27%11.49B | -28.97%8.52B | -32.92%5.57B | -42.10%2.83B | 43.92%16.02B | 60.74%12B | 87.91%8.3B |
| Net cash flows from financing activities | 191.52%279.34M | 630.33%356.14M | -258.62%-489.39M | 84.28%-704.14M | 90.78%-305.23M | 93.33%-67.15M | 146.19%308.53M | -1,523.69%-4.48B | -412.85%-3.31B | -202.40%-1.01B |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -12.08%8.07M | 15.33%8.66M | 295.05%2.48M | 43.01%12.07M | -21.32%9.18M | 101.96%7.51M | -1,302.31%-1.27M | 369.18%8.44M | 1,056.83%11.66M | 392.27%3.72M |
| Net increase in cash and cash equivalents | 759.54%865.19M | 1,878.48%920.56M | -129.77%-112.51M | 86.24%-549.56M | 95.82%-131.18M | 94.59%-51.76M | 151.33%377.97M | -785.80%-3.99B | -398.28%-3.14B | -238.49%-956.55M |
| Add:Begin period cash and cash equivalents | -52.11%505M | -52.11%505M | -52.11%505M | -79.11%1.05B | -79.11%1.05B | -79.11%1.05B | -79.11%1.05B | 13.04%5.05B | 13.04%5.05B | 13.04%5.05B |
| End period cash equivalent | 48.39%1.37B | 42.16%1.43B | -72.60%392.49M | -52.11%505M | -51.61%923.39M | -75.50%1B | -66.78%1.43B | -79.11%1.05B | -65.42%1.91B | -20.65%4.09B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Zhongtianyun Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | Zhongtianyun Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
